Annexon, Inc.
US ˙ NasdaqGS ˙ US03589W1027

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jung Choi. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jung Choi har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:GBT / Global Blood Therapeutics Inc. See Remarks 0
US:ANNX / Annexon, Inc. Director 10.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jung Choi. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ANNX / Annexon, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ANNX / Annexon, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANNX / Annexon, Inc. Insider Trades
Insidersalg ANNX / Annexon, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ANNX / Annexon, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ANNX / Annexon, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jung Choi som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -25.000 0 -100,00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -226.672 0 -100,00
2022-09-29 2022-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -73.855 226.672 -24,58
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.674 300.527 0,90 3,40 9.092 1.021.792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.674 300.527 0,90 3,40 9.092 1.021.792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 74.964 295.179 34,04 3,40 254.878 1.003.609
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.275 220.215 1,04 65,82 149.740 14.494.551
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 16.902 217.940 8,41 16,40 277.193 3.574.216
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.861 201.038 -0,92 68,15 -126.827 13.700.740
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.208 202.899 1,10
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 200.691 1,40
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.126 197.928 -1,06 32,40 -68.882 6.412.867
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.145 200.054 3,17
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28.628 28.628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.763 16.577 -14,29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -956 191.374 -0,50 29,87 -28.556 5.716.341
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 192.330 1,46
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 12.080 -20,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 6.250 -33,33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 0 -100,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.340 189.567 -1,73 29,33 -97.962 5.560.000
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 192.907 4,91
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.743 182.367 -2,01 27,33 -102.296 4.984.090
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 186.110 5,09
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.762 19.340 -12,50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.370 183.887 -0,74 29,85 -40.894 5.489.027
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.762 185.257 1,51
2021-09-03 2021-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 128 182.495 0,07 24,39 3.122 4.451.053
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.743 182.367 -2,01 27,33 -102.296 4.984.090
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 186.110 5,09
2021-06-04 2021-06-02 4 ANNX Annexon, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22.102 22.102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.739 38.739
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 140 177.090 0,08 36,21 5.069 6.412.429
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 18.120 -14,29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 12.500 -20,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 5.750 -33,33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 0 -100,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.646 176.950 -2,56 49,49 -229.931 8.757.256
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13.083 181.596 7,76
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 21.140 -12,50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 15.625 -16,67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 8.625 -25,00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 4.063 -49,99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -6.239 168.513 -3,57 67,48 -421.008 11.371.257
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13.082 174.752 8,09
2020-08-04 2020-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 162 161.670 0,10 36,68 5.942 5.930.056
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42.400 42.400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.500 38.500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24.160 24.160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 18.750 -14,29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 11.500 -20,00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 8.125 -33,34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.570 161.508 -2,16 65,26 -232.978 10.540.012
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10.063 165.078 6,49
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 286 155.015 0,18 36,68 10.490 5.685.950
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5.000 0 -100,00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.479 154.729 -1,58 76,88 -190.586 11.895.566
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5.000 157.208 3,28
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 21.875 -12,50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 14.375 -16,67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 12.188 -25,00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.990 152.208 -2,55 54,25 -216.458 8.257.284
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10.062 156.198 6,89
2019-08-05 2019-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 285 146.136 0,20 36,68 10.454 5.360.268
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 5.000 -28,57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 145.851 -0,47 58,51 -40.489 8.533.742
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 146.543 1,38
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 269 144.543 0,19 36,68 9.867 5.301.837
2019-02-14 2018-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 277 144.274 0,19 35,53 9.842 5.126.055
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 17.250 -14,29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 16.250 -20,00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25.000 25.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40.000 40.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.515 143.997 -1,72 48,44 -121.827 6.975.215
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.938 146.512 4,97
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 20.125 -12,50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 20.313 -16,66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.440 139.574 -2,41 43,15 -148.436 6.022.618
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.937 143.014 5,10
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2.675 -18,35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2.675 -18,35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 74.964 -0,26
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.077 -1,02 48,25 -67.550 6.565.715
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.477 0,44 3,40 2.043 467.422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.477 0,44 3,40 2.043 467.422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136.275 0,15 3,40 673 463.335
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 136.077 -1,16 48,25 -77.200 6.565.715
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.276 -15,50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.276 -15,50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.162 -0,26
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 137.677 -1,01 45,50 -63.700 6.264.304
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.077 0,43 3,40 2.043 472.862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.077 0,43 3,40 2.043 472.862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137.875 0,14 3,40 673 468.775
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 137.677 -1,15 45,50 -72.800 6.264.304
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.877 -13,42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.877 -13,42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.360 -0,26
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 139.277 -1,00 54,15 -75.810 7.541.850
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140.677 0,43 3,40 2.043 478.302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140.677 0,43 3,40 2.043 478.302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 139.475 0,14 3,40 673 474.215
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 139.277 -1,14 54,15 -86.640 7.541.850
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4.478 -11,83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4.478 -11,83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.558 -0,26
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 140.877 -0,98 62,95 -88.130 8.868.207
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142.277 0,42 3,40 2.043 483.742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142.277 0,42 3,40 2.043 483.742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141.075 0,14 3,40 673 479.655
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 140.877 -1,12 62,95 -100.720 8.868.207
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 7.000 -22,22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 142.477 -0,48 62,30 -43.112 8.876.317
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 143.169 1,42
2018-02-14 2017-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 676 135.931 0,50 13,69 9.254 1.860.895
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23.000 23.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 24.375 -14,29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.405 140.058 -0,99 59,60 -83.738 8.347.457
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4.063 141.463 2,96
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 9.000 -18,18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 137.400 -0,50 57,90 -40.067 7.955.460
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 138.092 1,47
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 11.000 -15,38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -686 136.092 -0,50 58,15 -39.891 7.913.750
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 136.778 1,48
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5.079 -10,58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5.079 -10,58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -198 75.756 -0,26
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 134.778 -1,17 52,85 -84.560 7.123.017
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.378 -1,02 52,85 -73.990 7.207.577
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.778 0,44 3,40 2.043 468.445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.778 0,44 3,40 2.043 468.445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136.576 0,15 3,40 673 464.358
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 13.000 -13,33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 136.378 -0,64 52,10 -45.692 7.105.294
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 137.255 1,48
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5.680 -9,57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5.680 -9,57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 75.954 -0,26
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 135.255 -1,02 36,55 -51.170 4.943.570
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136.655 0,44 3,40 2.043 464.627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136.655 0,44 3,40 2.043 464.627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 135.453 0,15 3,40 673 460.540
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 135.255 -1,17 36,55 -58.480 4.943.570
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.281 -8,73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.281 -8,73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.152 -0,26
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.855 -1,01 39,75 -55.650 5.439.986
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138.255 0,44 3,40 2.043 470.067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138.255 0,44 3,40 2.043 470.067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137.053 0,14 3,40 673 465.980
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 136.855 -1,16 39,75 -63.600 5.439.986
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.882 -8,03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.882 -8,03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.350 -0,26
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 138.455 -1,00 32,65 -45.710 4.520.556
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.855 0,43 3,40 2.043 475.507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.855 0,43 3,40 2.043 475.507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 138.653 0,14 3,40 673 471.420
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 138.455 -1,14 32,65 -52.240 4.520.556
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7.483 -7,43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7.483 -7,43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.548 -0,26
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 140.055 -0,99 30,00 -42.000 4.201.650
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141.455 0,43 3,40 2.043 480.947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141.455 0,43 3,40 2.043 480.947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 140.253 0,14 3,40 673 476.860
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 140.055 -1,13 30,00 -48.000 4.201.650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.084 -6,92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.084 -6,92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.746 -0,26
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 141.655 -0,98 30,00 -42.000 4.249.650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143.055 0,42 3,40 2.043 486.387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143.055 0,42 3,40 2.043 486.387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141.853 0,14 3,40 673 482.300
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 141.655 -1,12 30,00 -48.000 4.249.650
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15.000 15.000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 28.438 -12,50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.527 145.790 -1,04 25,10 -38.328 3.659.329
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4.062 147.317 2,84
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.685 -6,47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.685 -6,47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.944 -0,26
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 143.255 -0,97 30,00 -42.000 4.297.650
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144.655 0,42 3,40 2.043 491.827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144.655 0,42 3,40 2.043 491.827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 143.453 0,14 3,40 673 487.740
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 143.255 -1,10 30,00 -48.000 4.297.650
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 658 144.855 0,46 13,73 9.034 1.988.859
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 591 144.197 0,41 15,20 8.983 2.191.794
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 49.000 49.000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 32.500 32.500
2016-10-03 2016-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9.286 9.286
2016-03-14 2016-03-10 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9.286 9.286
2016-03-14 2016-02-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 143.606 0,52 16,09 12.051 2.310.621
2016-03-14 2015-08-17 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25.000 25.000 20,00 500.000 500.000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 168.606 0,45 16,09 12.051 2.712.871
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25.000 167.857 17,50 20,00 500.000 3.357.140
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285.714
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285.714
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)